08:00 , Dec 20, 2012 |  BC Innovations  |  Strategy

MRC Technology extends reach

After six years of focusing on developing small molecule drug candidates and humanizing therapeutic mAbs, both mostly from U.K. source, MRC Technology, the commercialization arm of the country's Medical Research Council, is taking its search...
07:00 , Aug 12, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Neurology

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy; seizures Galanin receptor 2 (GALR2) Cell culture and mouse studies identified a nonpeptide compound that could...
08:00 , Feb 18, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Indication

Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Epilepsy; seizures Galanin receptor 2 (GALR2) In vitro and mouse studies identified a GALR2-selective galanin analog that...